MitoQ Ltd   Report issue

For profit Phase 2
Founded: Auckland New Zealand (2005)
Status: No NME R&D (2005)

Organization Overview

First Clinical Trial
2017
NCT03166800
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

MitoQ

Active Ingredients

Drugs in Phase 2 Trials (2)

mitoquinone (1 trial)

ubiquinone (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Fatigue (Phase 2)

Inflammation (Phase 2)

Multiple Sclerosis (Phase 2)

Sclerosis (Phase 2)

Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2